JaeSang Ko Selected Research

JaeSang Ko Research Topics

Disease

16	Graves Ophthalmopathy 12/2023 - 01/2017
8	Inflammation (Inflammations) 12/2023 - 01/2018
4	Fibrosis (Cirrhosis) 12/2023 - 01/2017
3	Graves Disease (Basedow Disease) 01/2023 - 01/2018
2	Neoplasms (Cancer) 01/2022 - 05/2021
1	Exophthalmos (Proptosis) 08/2023
1	Blepharoptosis (Ptosis, Eyelid) 01/2023
1	Sarcopenia 01/2023
1	Enophthalmos 09/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Hypersensitivity (Allergy) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Lacrimal Apparatus Diseases (Epiphora) 01/2020
1	Lacrimal Duct Obstruction 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Gastroesophageal Reflux (GERD) 01/2019
1	Communicable Diseases (Infectious Diseases) 12/2017
1	Orbital lymphoma 12/2017
1	Keratitis 12/2017
1	Drug-Related Side Effects and Adverse Reactions 12/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 12/2017
1	Meibomian Gland Dysfunction 12/2017
1	Infections 10/2017

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2017
3	CytokinesIBA 01/2023 - 01/2020
2	Therapeutic UsesIBA 01/2022 - 01/2022
2	Fibronectins (Fibronectin)IBA 01/2022 - 01/2017
2	CollagenIBA 01/2022 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2023
1	Complement Factor D (Factor D)IBA 01/2023
1	ORALIT (ORS)IBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	ibrutinibIBA 01/2022
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2022
1	SeleniumIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	Thyroid-Stimulating ImmunoglobulinsIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 11/2021
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	GadoliniumIBA 05/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Caffeine (No Doz)FDA LinkGeneric 04/2020
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	MetalsIBA 01/2020
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2020
1	SiliconesIBA 01/2020
1	Superoxide DismutaseIBA 01/2020
1	ThioredoxinsIBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Proprotein Convertase 9IBA 01/2020
1	LeptinIBA 01/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020
1	PPAR gammaIBA 01/2020
1	Heme Oxygenase-1IBA 01/2020
1	EnzymesIBA 01/2020
1	Proton Pump InhibitorsIBA 01/2019
1	idelalisibIBA 01/2018
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018
1	Moxifloxacin (Avelox)FDA Link 12/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2017
1	sphingosine kinaseIBA 01/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	JTE 013IBA 01/2017

Therapy/Procedure

1	Decompression 08/2023
1	Absorbable Implants 09/2022
1	Contact Lenses 01/2021
1	Slit Lamp 01/2021
1	Stents 01/2020
1	Radiotherapy 12/2017
1	Laser In Situ Keratomileusis (LASIK) 12/2017
1	Artificial Eye (Artificial Eyes) 10/2017